Coagulation Studies: PT/INR, aPTT, D-dimer, and Fibrinogen Demystified

 

Coagulation Studies: PT/INR, aPTT, D-dimer, and Fibrinogen Demystified

When a prolonged aPTT is lupus anticoagulant vs. factor deficiency vs. heparin contamination—and why D-dimer is the most overordered test in the ED.

Coagulation studies get ordered constantly but are interpreted correctly far less often. The most common mistakes: ordering a D-dimer on a patient who clearly needs imaging, panicking about a mildly prolonged aPTT in a preop patient, and missing the lupus anticoagulant connection that ties directly into this series. Let's decode the panel.

The Tests and What They Measure

Test	Pathway	What It Assesses	Prolonged By
PT (Prothrombin Time) / INR	Extrinsic + common pathway (Factors VII, X, V, II, fibrinogen)	Warfarin monitoring; liver synthetic function	Warfarin, liver disease, vitamin K deficiency, DIC, factor VII deficiency
aPTT (Activated Partial Thromboplastin Time)	Intrinsic + common pathway (Factors XII, XI, IX, VIII, X, V, II, fibrinogen)	Heparin monitoring; intrinsic factor deficiencies; lupus anticoagulant screen	Heparin, factor deficiencies (hemophilia A/B), lupus anticoagulant, von Willebrand disease, DIC
D-dimer	Fibrinolysis	Detects fibrin degradation products	VTE, PE, DIC, surgery, trauma, pregnancy, malignancy, infection, inflammation, age
Fibrinogen	Common pathway	Clotting substrate; acute-phase reactant	Low in DIC, severe liver disease, massive hemorrhage. High in inflammation, pregnancy.

The Interpretation Patterns

PT/INR	aPTT	Think About
Prolonged	Normal	Warfarin therapy, early vitamin K deficiency, early liver disease, isolated factor VII deficiency
Normal	Prolonged	Heparin therapy, lupus anticoagulant, hemophilia A (factor VIII) or B (factor IX), von Willebrand disease, factor XI/XII deficiency, specimen contamination with heparin
Prolonged	Prolonged	DIC, severe liver disease, common pathway factor deficiency (X, V, II, fibrinogen), supratherapeutic anticoagulation, massive transfusion
Normal	Normal	Normal coagulation; does NOT exclude platelet disorders or von Willebrand disease (mild forms may have normal aPTT)

The Mixing Study: The Tiebreaker

When the aPTT is prolonged and the cause is unclear, a mixing study is the next step. The patient's plasma is mixed 1:1 with normal pooled plasma:

• aPTT corrects (normalizes with mixing): Factor deficiency—the normal plasma provides the missing factor. Investigate for hemophilia, vWD, or other factor deficiencies.
• aPTT does NOT correct: An inhibitor is present, blocking the coagulation pathway. The two most common inhibitors: lupus anticoagulant (the most common) and acquired factor VIII inhibitor (rare but serious).

The Lupus Anticoagulant Connection

This ties directly to the antiphospholipid antibody post in this series. Lupus anticoagulant (LA) paradoxically prolongs the aPTT in vitro but causes clotting in vivo. A prolonged aPTT that doesn't correct on mixing study + clinical thrombosis = suspect APS. Key points: LA interferes with phospholipid-dependent coagulation assays (hence the prolonged aPTT), but it's a pro-thrombotic condition. Never give a patient with suspected APS FFP or factor replacement for a "prolonged aPTT"—the prolongation is the antibody, not a bleeding diathesis.

D-dimer: The Most Overordered Test in Emergency Medicine

When D-dimer Is Useful

D-dimer has high sensitivity but low specificity for VTE. Its clinical value is as a rule-out test in low-to-moderate pretest probability patients:

• Low/moderate Wells score for PE or DVT + negative D-dimer = VTE excluded. No imaging needed.
• Age-adjusted D-dimer cutoffs (age × 10 for patients >50) improve specificity without sacrificing sensitivity.

When D-dimer Is Useless (or Harmful)

• High pretest probability: If the Wells score indicates PE/DVT is likely, skip the D-dimer and go straight to imaging (CT-PA or duplex ultrasound). A negative D-dimer in high-probability patients does NOT reliably exclude VTE.
• Hospitalized patients: D-dimer is elevated in almost every hospitalized patient (surgery, infection, inflammation, immobilization). It has almost zero specificity in this population.
• Pregnancy: D-dimer rises physiologically throughout pregnancy. Standard cutoffs don't apply. Imaging is generally preferred for suspected VTE in pregnancy.
• Active cancer, recent surgery, trauma, elderly patients: D-dimer is chronically elevated. A positive result tells you nothing useful.

The Harm of Overordering

Ordering D-dimer on a high-probability patient creates a dilemma: if it's negative (which it sometimes is even with PE), you might falsely reassure yourself. If it's positive (which it almost always is in sick patients), you've ordered a useless test that now mandates imaging anyway. Use clinical decision rules (Wells, PERC) first. D-dimer is for low/intermediate probability only.

D-dimer in DIC

In the context of sepsis or obstetric emergencies, a markedly elevated D-dimer with concurrent thrombocytopenia, prolonged PT/aPTT, and low fibrinogen = DIC. Here, D-dimer has a different role: it's part of the DIC score, not a VTE screen.

Fibrinogen: The Overlooked Marker

• Low fibrinogen (<200): DIC (consumed), severe liver disease (not synthesized), massive hemorrhage (diluted), rare congenital hypofibrinogenemia
• Very low fibrinogen (<100): Critical—risk of uncontrollable bleeding. Replace with cryoprecipitate.
• High fibrinogen: Acute-phase reactant. Elevated in infection, inflammation, pregnancy, malignancy. Also an independent cardiovascular risk factor.

DIC: The Pattern to Recognize

DIC is not a single lab result—it's a pattern across multiple tests in the right clinical context (sepsis, trauma, obstetric emergency, malignancy):

• Prolonged PT and aPTT
• Thrombocytopenia (platelets being consumed)
• Elevated D-dimer (fibrinolysis)
• Low fibrinogen (consumed)
• Schistocytes on peripheral blood smear (microangiopathic hemolysis)

Pediatric Note

Neonates have physiologically prolonged PT and aPTT due to immature clotting factor production (especially vitamin K-dependent factors). This normalizes by 6 months. Always use age-appropriate reference ranges for neonatal and pediatric coagulation studies. Vitamin K deficiency bleeding (formerly "hemorrhagic disease of the newborn") is prevented by routine vitamin K injection at birth—a critical reason to never skip it.

Preoperative Coagulation Testing: When It's Needed (and When It Isn't)

Routine preoperative PT/aPTT in patients with no personal or family history of bleeding and no clinical evidence of a bleeding disorder is not recommended per multiple Choosing Wisely guidelines. A thorough bleeding history is more informative than reflexive lab testing.

Order preoperative coagulation studies when: known bleeding disorder, anticoagulant use, liver disease, malnutrition, suspected malabsorption, or a positive bleeding history (easy bruising, heavy menses, prolonged bleeding after dental procedures or surgeries, family history of hemophilia or vWD).

The Pitfalls

• Heparin contamination: The most common cause of a falsely prolonged aPTT in hospitalized patients is a specimen drawn from a heparinized line. Always draw from a non-heparinized site or waste adequately before collecting.
• Assuming prolonged aPTT = bleeding risk: Lupus anticoagulant prolongs aPTT but causes thrombosis, not bleeding. Factor XII deficiency prolongs aPTT but has NO bleeding risk. The aPTT is not a bleeding predictor—it's a pathway assay.
• Using D-dimer as a screening test: D-dimer should only be ordered after calculating pretest probability. It is NOT a screening test for VTE.
• Forgetting that PT/INR reflects liver function: In a patient with no anticoagulant use, an elevated INR = impaired hepatic synthetic function until proven otherwise.
• Not checking fibrinogen in suspected DIC: Fibrinogen is often the forgotten component of the DIC workup. A falling fibrinogen is one of the most specific signs.
• Interpreting neonatal coag studies with adult norms: Neonates are physiologically "prolonged." Use neonatal reference ranges.

Bottom Line

PT measures the extrinsic pathway and liver synthetic function. aPTT measures the intrinsic pathway and is the test affected by heparin and lupus anticoagulant. D-dimer rules out VTE in low-probability patients and is useless in high-probability or hospitalized patients. Fibrinogen is the acute-phase reactant you're forgetting to check in DIC. And a prolonged aPTT that doesn't correct on mixing is lupus anticoagulant until proven otherwise—which means clotting, not bleeding.

Stay sharp out there.